Healthcare Leaders Study Lazard 2019

Reports and studies — New York,

March 07, 2019

The executive respondents represented many of the largest healthcare companies globally.

The results of the 2019 Global Healthcare Leaders Study echo the concerns that healthcare executives expressed in 2017 on the need to address rising cost trends with value-based pricing models and scientific innovation. This year’s results, however, showed an increased focus on the potential impact of technological advances in artificial intelligence, machine learning and data analytics.

The central findings of the study include:

Pricing and reimbursement pressure continue to be among the top strategic challenges facing the industry

Transformation over the next 5-10 years is expected to come from different sources across healthcare sectors

Data analytics, artificial intelligence and machine learning are expected to have a transformative impact on the industry over the next five years

Pricing/reimbursement pressure and the need for innovation continue to drive strategic activity among healthcare companies

Download the review to read the findings in full.